Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Marbán, Eduardo  [Clear All Filters]
2014
Cheng K, Malliaras K, Smith RRuckdesche, Shen D, Sun B, Blusztajn A, Xie Y, Ibrahim A, Aminzadeh MAmin, Liu W, et al. Human Cardiosphere-Derived Cells From Advanced Heart Failure Patients Exhibit Augmented Functional Potency in Myocardial Repair. JACC Heart Fail. 2014;2(1):49-61.
2015
Marbán E, Cingolani E. Direct Reprogramming: Bypassing Stem Cells for Therapeutics. JAMA. 2015;314(1):19-20.
de Couto G, Liu W, Tseliou E, Sun B, Makkar N, Kanazawa H, Arditi M, Marbán E. Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J Clin Invest. 2015.
2016
Tseliou E, Kanazawa H, Dawkins J, Gallet R, Kreke M, Smith R, Middleton R, Valle J, Marbán L, Kar S, et al. Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology. PLoS One. 2016;11(1):e0144523.
2019
Liang W, Han P, Kim EH, Mak J, Zhang R, Torrente AG, Goldhaber JI, Marbán E, Cho HCheol. Canonical Wnt signaling promotes pacemaker cell specification of cardiac mesodermal cells derived from mouse and human embryonic stem cells. Stem Cells. 2019.
2022
C Merz NBairey, Marbán E. Stem Cell Therapy Targets: Repêchage!. Circ Res. 2022;130(3):339-342.
2023
Lewis MI, Shapiro S, Oudiz RJ, Nakamura M, Geft D, Matusov Y, Hage A, Tapson VF, Henry TD, Azizad P, et al. The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells. EBioMedicine. 2023:104900.